Skip to content
Aspivix logo
  • News
  • About us
  • Contact
  • Distribution Network
  • English
    • Français
    • Italiano
    • Deutsch
Buy Now
Search
Close
  • For Healthcare Professionals
  • For Women
  • Find your OBGYN
  • Resources
  • News
  • About us
  • Contact
  • Distribution Network
  • English
    • Français
    • Italiano
    • Deutsch
Buy Now
  • For Healthcare Professionals
  • For Women
  • Find your OBGYN
  • Resources
Aspivix logo
Home > News

Press Contact
For media enquiries, please reach out to: contact@aspivix.com

All
  • All
  • Blog
  • In the media
  • Press releases
75

Innovation in women’s health comes in small doses

December 30, 2020
Read More about Innovation in women’s health comes in small doses
76

5 Top Emerging Reproductive Health Startups

December 30, 2020
Read More about 5 Top Emerging Reproductive Health Startups
77

Les premières données cliniques tombent pour Aspivix, et elles sont réjouissantes !

December 17, 2020
Read More about Les premières données cliniques tombent pour Aspivix, et elles sont réjouissantes !
78

ASPIVIX’s Press Release featured in Investhirozon.eu

December 14, 2020
Read More about ASPIVIX’s Press Release featured in Investhirozon.eu
50

ASPIVIX Reports Positive First-in-Women Results Using Novel Suction-based Cervical Device in IUD Procedures

December 12, 2020
RENENS, Switzerland, Dec. 10, 2020 /PRNewswire/ — ASPIVIX SA, a developer of medical technologies to advance gynecological care, today announced completion of and interim analysis results from its Phase I first-in-women trial. The ADVANCE Women (Atraumatic...
Read More about ASPIVIX Reports Positive First-in-Women Results Using Novel Suction-based Cervical Device in IUD Procedures
79

It’s Time For The Next-Generation Gentle and Modern Gynecology

December 11, 2020
Read More about It’s Time For The Next-Generation Gentle and Modern Gynecology
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
Loading... loader
Scroll to learn more

Company

  • Home
  • Product
  • Resources
  • Careers
  • News

Contact

Global Headquarters
Aspivix SA
Route de la Corniche 8
1066 Epalinges
Switzerland

contact@aspivix.com

Legal

  • Cookie Policy
  • Privacy Statement
  • Imprint
  • Disclaimer

Follow

Carevix® is currently FDA-Cleared for US market, CE-Marked for EU market and authorized in UK and Brazil. Available for commercialization. It has not been licensed or approved for sale in other markets.

© 2026 Aspivix SA. All rights reserved. Aspivix™, and Carevix® are trademarks or registered trademarks of Aspivix SA and/or its subsidiaries.

Where are you located?

Europe
United States

Where are you located?

Europe
United States